Anebulo Pharmaceuticals, Inc. (ANEB) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts ANEB Hot Sheet
Join SI Premium – FREE
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- EU opens antidumping review of Chinese silicon metal imports
- Medtronic jumps on earnings beat and raised guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
